Status: current, Primitive. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3717570017 | Bictegravir (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3717571018 | Bictegravir | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Bictegravir | Is a | Heterocyclic compound | true | Inferred relationship | Some | ||
| Bictegravir | Has disposition | Integrase strand transfer inhibitor | true | Inferred relationship | Some | ||
| Bictegravir | Is a | Nucleotidyltransferase inhibitor | false | Inferred relationship | Some | ||
| Bictegravir | Is a | Integrase strand transfer inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Bictegravir sodium | Is modification of | True | Bictegravir | Inferred relationship | Some | |
| Bictegravir- and emtricitabine- and tenofovir-containing product in oral dose form | Has active ingredient | True | Bictegravir | Inferred relationship | Some | 3 |
| Bictegravir- and emtricitabine- and tenofovir-containing product | Has active ingredient | True | Bictegravir | Inferred relationship | Some | 3 |
| Bictegravir and emtricitabine and tenofovir only product | Has active ingredient | True | Bictegravir | Inferred relationship | Some | 3 |
| Bictegravir and emtricitabine and tenofovir only product in oral dose form | Has active ingredient | True | Bictegravir | Inferred relationship | Some | 3 |
| Bictegravir-containing product | Has active ingredient | True | Bictegravir | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR